查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375863

介入性心臟病學設備市場規模、佔有率和趨勢分析報告：2023-2030 年按產品、地區和細分市場分類的趨勢

Interventional Cardiology Devices Market Size, Share & Trends Analysis Report By Product (Coronary Stents, PTCA Balloon Catheters, Accessory Devices), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

介入性心臟病學設備市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球介入性心臟病設備市場規模預計將達到 223.5 億美元。

預計2023年至2030年該市場將以7.2%的年複合成長率擴張。由於冠狀動脈介入手術的優惠報銷政策、全球心血管疾病（CVD）和糖尿病盛行率的上升以及市場上新產品線的推出，對介入性心臟病學設備的需求正在上升。心血管疾病是全世界死亡和罹患率的主要原因之一。冠狀動脈疾病和先天性心臟疾病是世界各地流行的主要心血管疾病。

此外，吸煙、久坐、用餐不當等不健康的生活方式也會導致糖尿病。心導管插入術、血管成形術和經皮冠狀動脈介入治療（PCI）是治療心血管疾病的主要手術。由於糖尿病是心血管疾病的主要原因之一，預計糖尿病患者數量的增加將在預測期內大幅增加對介入性心臟病學設備的需求。儘管市場預計在未來年度將擴大，但由於醫療設備價格高昂，成長可能會放緩，特別是在保險覆蓋範圍不足的新興經濟體。

介入性心臟病學市場報告亮點

  • 冠脈支架領域將在2022年以64.6%的銷售佔有率佔據市場主導地位。 DES 佔冠狀動脈支架部門銷售額的大部分
  • 冠狀動脈支架的技術進步，例如分叉支架的開發和生物分解性材料的使用，導致了更有效的CVD治療和改善的結果。每家公司都積極參與產品開發、合作夥伴關係和策略聯盟。上述因素預計將在預測期內推動產業成長。
  • 預計亞太地區在預測期內將以 7.9% 的最快年複合成長率成長。這種成長是由於多種因素造成的，包括冠狀動脈疾病（CAD）罹患率的增加以及針對這種疾病的篩檢措施的改進。
  • 由於多家公司的存在，市場變得分散。因此，預計未來年度競爭將會加劇。市場參與企業正在採取各種策略舉措，例如聯盟、銷售和行銷活動、併購、服務擴展、整合產品和產品發布，以增強其在市場中的影響力。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 介入性心臟病學設備市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 心臟介入設備市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 心臟介入器材市場：產品預估及趨勢分析

  • 心臟介入器材市場：重點
  • 心臟介入器材市場：2022年及2030年產品趨勢及市場佔有率分析
  • 冠狀動脈支架
  • PTCA球囊導管
  • 附屬裝置
  • 血管成像導管和壓力導絲

第5章 心臟介入器材市場：區域估算及趨勢分析

  • 區域展望
  • 按地區分類的心臟介入器材市場：要點
  • 北美洲
    • 2018-2030 年北美市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030 年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018 年至 2030 年 MEA 市場估計與預測
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Abbott Laboratories
    • Medtronic
    • Boston Scientific
    • Spectranetics
    • Cardinal Health
    • Philips Healthcare
    • Terumo
    • Alvimedica
    • Teleflex Medical
    • B. Braun
    • Biosensors International
    • Meril Life Sciences
    • BIOTRONIK
    • ACIST Medical Systems
    • ASAHI INTECC
    • CID Vascular
    • Cook Medical
    • Medinol
    • Merit Medical Systems
    • NuMED
    • OpSens
    • Vascular Solutions
    • Zeon Medical
Product Code: 978-1-68038-122-1

Interventional Cardiology Devices Market Growth & Trends:

The global interventional cardiology devices market size is expected to reach USD 22.35 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 7.2% from 2023 to 2030 Demand for interventional cardiology devices is on the rise owing to favorable reimbursement policies for coronary intervention procedures, rising prevalence of cardiovascular diseases (CVDs) and diabetes across the globe, and the launch of new product lines in the market. Cardiovascular diseases have become one of the major causes of mortality and morbidity in the world. Coronary artery disease and congenital heart defects are the major cardiovascular diseases that are prevalent across the globe.

Furthermore, the adoption of unhealthy lifestyles, such as smoking, a sedentary lifestyle, and improper diet, is responsible for diabetes. Cardiac catheterization, angioplasty, and Percutaneous Coronary Intervention (PCI) are some of the major procedures used for the treatment of cardiovascular diseases. Since diabetes is one of the major reasons behind triggering cardiovascular diseases, increasing diabetes cases are expected to surge the demand for interventional cardiology devices over the forecast period. Although the market is anticipated to expand over the coming years, it might witness slower growth possibly brought on by the high price of medical devices, especially in developing economies with insufficient insurance coverage.

Interventional Cardiology Devices Market Report Highlights:

  • The coronary stents segment dominated the market with the largest revenue share of 64.6% in 2022. DES makes up the majority of sales in the coronary stent category.
  • Technological advancements in coronary stents, such as the development of bifurcated stents and the use of biodegradable materials, have led to efficient and improved outcomes of CVD treatment. Companies are proactively involved in product developments and partnerships and strategic collaborations. The aforementioned factors are expected to propel industry growth over the forecast period
  • Asia Pacific region is expected to advance at the fastest CAGR of 7.9% over the forecast period. This growth can be attributed to several factors, including the increasing incidence of coronary artery disease (CAD) and improved screening measures for this disorder.
  • The market is fragmented due to the presence of several players. This is expected to intensify the competition in the coming years. Market players are adopting various strategic initiatives such as partnerships, sales & marketing activities, mergers & acquisitions, service expansion, integrated offerings, and product launches to increase their market presence

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Interventional Cardiology Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Interventional Cardiology Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Interventional Cardiology Devices Market: Product Estimates & Trend Analysis

  • 4.1. Interventional Cardiology Devices Market: Key Takeaways
  • 4.2. Interventional Cardiology Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Coronary Stents
    • 4.3.1. Coronary stents market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. DES
      • 4.3.2.1. DES market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. BMS
      • 4.3.3.1. BMS market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. BRS
      • 4.3.4.1. BRS market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. PTCA Balloon Catheters
    • 4.4.1. PTCA balloon catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Normal
      • 4.4.2.1. Normal market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Specialty
      • 4.4.3.1. Specialty market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. DCB
      • 4.4.4.1. DCB market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Accessory Devices
    • 4.5.1. Accessory devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. PTCA guidewires
      • 4.5.2.1. PTCA guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Diagnostic catheters
      • 4.5.3.1. Diagnostic catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. PTCA guiding catheters
      • 4.5.4.1. PTCA guiding catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.5. Introducer sheaths
      • 4.5.5.1. Introducer sheaths market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Intravascular imaging catheters and pressure guidewires
    • 4.6.1. Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Interventional Cardiology Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Interventional Cardiology Devices Market by Region: Key Takeaways
  • 5.3. North America
    • 5.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. UK
      • 5.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. France
      • 5.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. China
      • 5.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. India
      • 5.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Mexico
      • 5.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.4. Argentina
      • 5.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. South Africa
      • 5.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Abbott Laboratories
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Medtronic
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Boston Scientific
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Spectranetics
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Cardinal Health
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Philips Healthcare
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Terumo
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Alvimedica
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Teleflex Medical
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. B. Braun
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. Biosensors International
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives
    • 6.2.12. Meril Life Sciences
      • 6.2.12.1. Company overview
      • 6.2.12.2. Financial performance
      • 6.2.12.3. Product benchmarking
      • 6.2.12.4. Strategic initiatives
    • 6.2.13. BIOTRONIK
      • 6.2.13.1. Company overview
      • 6.2.13.2. Financial performance
      • 6.2.13.3. Product benchmarking
      • 6.2.13.4. Strategic initiatives
    • 6.2.14. ACIST Medical Systems
      • 6.2.14.1. Company overview
      • 6.2.14.2. Financial performance
      • 6.2.14.3. Product benchmarking
      • 6.2.14.4. Strategic initiatives
    • 6.2.15. ASAHI INTECC
      • 6.2.15.1. Company overview
      • 6.2.15.2. Financial performance
      • 6.2.15.3. Product benchmarking
      • 6.2.15.4. Strategic initiatives
    • 6.2.16. CID Vascular
      • 6.2.16.1. Company overview
      • 6.2.16.2. Financial performance
      • 6.2.16.3. Product benchmarking
      • 6.2.16.4. Strategic initiatives
    • 6.2.17. Cook Medical
      • 6.2.17.1. Company overview
      • 6.2.17.2. Financial performance
      • 6.2.17.3. Product benchmarking
      • 6.2.17.4. Strategic initiatives
    • 6.2.18. Medinol
      • 6.2.18.1. Company overview
      • 6.2.18.2. Financial performance
      • 6.2.18.3. Product benchmarking
      • 6.2.18.4. Strategic initiatives
    • 6.2.19. Merit Medical Systems
      • 6.2.19.1. Company overview
      • 6.2.19.2. Financial performance
      • 6.2.19.3. Product benchmarking
      • 6.2.19.4. Strategic initiatives
    • 6.2.20. NuMED
      • 6.2.20.1. Company overview
      • 6.2.20.2. Financial performance
      • 6.2.20.3. Product benchmarking
      • 6.2.20.4. Strategic initiatives
    • 6.2.21. OpSens
      • 6.2.21.1. Company overview
      • 6.2.21.2. Financial performance
      • 6.2.21.3. Product benchmarking
      • 6.2.21.4. Strategic initiatives
    • 6.2.22. Vascular Solutions
      • 6.2.22.1. Company overview
      • 6.2.22.2. Financial performance
      • 6.2.22.3. Product benchmarking
      • 6.2.22.4. Strategic initiatives
    • 6.2.23. Zeon Medical
      • 6.2.23.1. Company overview
      • 6.2.23.2. Financial performance
      • 6.2.23.3. Product benchmarking
      • 6.2.23.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 France interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 China interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 Japan interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 India interventional cardiology devices market, by product, 2018 - 2030, (USD Million)
  • Table 21 Australia interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait interventional cardiology devices market, by product, 2018 - 2030 (USD Million) 

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Interventional cardiology devices: Market outlook
  • Fig. 9 Interventional cardiology devices: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Interventional cardiology devices market driver impact
  • Fig. 15 Interventional cardiology devices market restraint impact
  • Fig. 16 Interventional cardiology devices market strategic initiatives analysis
  • Fig. 17 Interventional cardiology devices market: Product movement analysis
  • Fig. 18 Interventional cardiology devices market: Product outlook and key takeaways
  • Fig. 19 Coronary stents market estimates and forecasts, 2018 - 2030, (USD million)
  • Fig. 20 DES market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 BMS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 BRS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 PTCA balloon catheters market estimates and forecasts, (USD million) 2018 - 2030
  • Fig. 24 Normal market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Specialty market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 DCB market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Accessory devices market estimates and forecasts, 2018 - 2030, (USD million)
  • Fig. 28 PTCA guidewires market estimates and forecasts, 2018 - 2030, (USD million)
  • Fig. 29 Diagnostic catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 PTCA guiding catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Introducer sheaths market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Intravascular imaging catheters and pressure guidewire market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Global interventional cardiology devices market: Regional movement analysis
  • Fig. 34 Global interventional cardiology devices market: Regional outlook and key takeaways
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 UAE market estimates and forecasts, 2018 -2030, (USD million)
  • Fig. 62 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)